Merck will continue DTC for Singulair, Januvia, says CFO

In an analyst call, Merck EVP and CFO Peter Kellogg said the company plans “continued DTC efforts for Singulair and Januvia as well as appropriate promotional support for Gardasil, RotaTeq and Zostavax,” along with support for the launch of Isentress and hopeful Cordaptive.

You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical